Results 161 to 170 of about 304,551 (334)
The paper is the second part of the study published in the previous issue of the same journal. The author describes the use of place names in a subculture that considers the Pilis Mountains the forgotten and destroyed scene of an ancient and glorious ...
Imreh, Réka
doaj
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
The paper presents the conclusions drawn from a 2010 questionnaire survey of adult language users’ knowledge about, and attitudes to their own names, family names from their places of residence and family names of occupational origin.
Schirm, Anita
doaj
Kiss Ulrich jezsuita szerzetestől hallottam az alábbi feladványt: „Mely társaság lehet egy 2000 éves cég 450 éves leányvállalata?” A válasz nyilvánvalóan nem a polgári törvénykönyvünk szerinti cégformában működő társaságok között keresendő, hanem valamiféle sokkal ősibb, lényeges társadalmi szükségletet kielégítő egyéb szervezetben, amely formáját ...
openaire +1 more source
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
Research into the mountain names of historical Hungary has been a neglected area of Hungarian Onomastics to date. However, mountains as important objects of the natural environment have significantly influenced the development of both settlement ...
Sebestyén, Zsolt
doaj
International Variation in Preoperative SNOT‐22 Scores: A Scoping Review and Exploratory Analysis
International Forum of Allergy &Rhinology, EarlyView.
Jaynelle Gao +8 more
wiley +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
Abstract Research evidence is mixed on the consequences of ability grouping policies, but most research has found an overrepresentation of disadvantaged social demographics in low‐ability groups. However, researchers have neglected to explain why ability grouping policies vary between countries.
Monica Reichenberg +2 more
wiley +1 more source
Abstract Within the educational literature, inter‐organisational school networks are commonly considered instruments for administration, management, and school improvement, but are rarely scrutinised as objects of study themselves. Conversely, in organisational studies, this perspective is given more prominence.
Ignacio Wyman, Paul Wilfred Armstrong
wiley +1 more source

